Structured products are again in the regulatory firing line but this time it is providers - rather than IFAs - which are in the FSA's sights.
In the latest clampdown on the much maligned products, recent guidance issued by the regulator said providers need to play a greater role in monitoring the distribution of structured products in order to reduce mis-selling. Findings from the FSA’s recent review of the structured product market suggest providers rely wholly on distributors to identify target markets, and such a strategy increases the potential for mis-selling. To ensure products are being sold only to suitable investors the FSA set out radical proposals requiring providers to carry out due diligence on distributors, in...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes